How To Buy A Xarelto Lawsuit On A Tight Budget
Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical businesses, which includes the makers of Xarelto, possess a duty to make sure that their drugs are reasonably secure for use - and failure to accomplish so could be grounds for compensation. Our lawyers are functioning hard to obtain these hurt by the drug the compensation they are entitled to.
Even though bleeding is really a typical complication linked with anticoagulants, it has been alleged that Xarelto is a lot more dangerous than standard blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This indicates that, in the event of an emergency, sufferers might be at risk for irreversible bleeding problems, such as life-threatening http://opal-festival.com/ internal and gastrointestinal hemorrhaging.
Should you or even a loved a single suffered a significant bleeding event following taking Xarelto, you may have legal recourse. For much more information, get in touch with us nowadays to possess your case reviewed, free of charge.
Compensation Possibilities
xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future healthcare bills, lost wages, discomfort and suffering and, in instances of death, funeral expenditures. Additionally, they may be seeking punitive damages, that are typically awarded to punish the defendant and deter other companies from acting similarly.
Why Are Lawsuits Becoming Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs within the lawsuits allege serious and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.
Visit this page for far more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
